Efficacy of an implantable cardioverter-defibrillator in a neonate with LQT3 associated arrhythmias

Europace

Volumn 7, Issue 1, 2005, Pages 77-84

  Ten Harkel, Arend D J ^a   Witsenburg, Maarten ^a   de Jong, Peter L ^b   Jordaens, Luc ^b   Wijman, Marjolein ^a   Wilde, Arthur A M ^c  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

ICD implantation; LQT3; Neonatal

Indexed keywords

FLECAINIDE; LIDOCAINE; MEXILETINE; SOTALOL;

ADULT; ARTICLE; CARDIOVERSION; CASE REPORT; DEFIBRILLATOR; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; LONG QT SYNDROME; NEWBORN; PRIORITY JOURNAL; QRS COMPLEX; SINUS RHYTHM;

DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; LONG QT SYNDROME;

EID: 12544250045     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eupc.2004.09.007     Document Type: Article

References (36)

1. P.J. Schwartz S.G. Priori C. Spazzolini et al. Genotype-phenotype correlation in the long-QT syndrome. Gene-specific triggers for life-threatening arrhythmias Circulation 103 2001 89-95
2. M. Hofbeck H. Ulmer E. Beinder E. Sieber H. Singer Prenatal findings in patients with prolonged QT interval in the neonatal period Heart 77 1997 198-204
3. A. Kandori T. Miyashita K. Tsukada et al. Prenatal diagnosis of QT prolongation by fetal magnetocardiogram - use of QRS and T-wave current-arrow maps Physiol Meas 22 2001 377-387
4. T. Menendez S. Achenbach E. Beinder et al. Prenatal diagnosis of QT prolongation by magnetocardiography Pacing Clin Electrophysiol 23 2000 1305-1307
5. N. Manning J.P. Anthony I. Ostman-Smith C.S. Snyder M. Burch Prenatal diagnosis and successful preterm delivery of a foetus with long QT syndrome Brit J Obstet Gynaecol 107 2000 1049-1051
6. M.T. Donofrio S.D. Gullquist N.G. O'Connell F.O. Redwine Fetal presentation of congenital long QT syndrome Pediatr Cardiol 20 1999 441-444
7. H. Hamada H. Horigome M. Asaka et al. Prenatal diagnosis of long QT syndrome using fetal magnetocardiography Prenat Diagn 19 1999 677-680
8. M. Yamada M. Nakazawa K. Momma Fetal ventricular tachycardia in long QT syndrome Cardiol Young 8 1998 119-122
9. C.J. Mache A. Beitzke M. Haidvogl Jr. A. Gamillscheg C. Suppan J.I. Stein Perinatal manifestations of idiopathic long QT syndrome Pediatr Cardiol 17 1996 118-121
10. D.L. Trippel M.K. Parsons P.C. Gillette Infants with long-QT syndrome and 2:1 atrioventricular block Am Heart J 130 1995 1130-1134
11. D.P. Southall W.A. Arrowsmith J.R. Oakley G. McEnery R.H. Anderson E.A. Shinebourne Prolonged QT interval and cardiac arrhythmias in two neonates: Sudden infant death syndrome in one case Arch Dis Child 54 1979 776-779
12. A. Ohkuchi H. Shiraishi H. Minakami Y. Eguchi A. Izumi I. Sato Fetus with long QT syndrome manifested by tachyarrhythmia: A case report Prenat Diagn 19 1999 990-992
13. H. Wedekind J.P.P. Smits E. Schulze-Bahr et al. De novo mutation in the SCN5A gene associated with early onset of sudden infant death Circulation 104 2001 1158-1164
14. T. Hoorntje M. Alders P. Van Tintelen Homozygous premature truncation of the HERG protein. The human HERG knockout Circulation 100 1999 1264-1267
15. J.M. Lupoglazoff I. Denjoy E. Villain et al. Long QT syndrome in neonates; conduction disorders associated with HERG mutations and sinus bradycardia with KCNQ1 mutations J Am Coll Cardiol 43 2004 826-830
16. W. Shimizu C. Antzelevitch Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome J Am Coll Cardiol 35 2000 778-786
17. +-channel blockade and to increases in heart rate Circulation 92 1995 3381-3386
18. W. Shimizu C. Antzelevitch Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade de pointes in LQT2 and LQT3 models of the long-QT syndrome Circulation 96 1997 2038-2047
19. A.J. Moss W. Zareba J. Hall et al. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome Circulation 101 2000 616-623
20. W.J. Groh M.J. Silka R.P. Oliver B.D. Halperin J.H. McAnulty J. Kron Use of implantable cardioverter-defibrillators in the congenital long QT syndrome Am J Cardiol 78 1996 703-706
21. S.G. Priori C. Napolitano P.J. Schwartz R. Bloise L. Crotti E. Ronchetti The elusive link between LQT3 and Brugada syndrome. The role of flecainide challenge Circulation 102 2000 945-947
22. P.J. Schwartz S.G. Priori R. Bloise et al. Molecular diagnosis in a child with sudden infant death syndrome Lancet 358 2001 1342-1343
23. P.J. Schwartz S.G. Priori R. Dumaine et al. A molecular link between the sudden infant death syndrome and the long-QT syndrome New Engl J Med 343 2000 262-267
24. P.J. Schwartz M. Stramba-Badiale A. Segantini et al. Prolongation of the QT interval and the sudden infant death syndrome New Engl J Med 338 1998 1709-1714
25. N.G. Kambouris H.B. Nuss D.C. Johns G.F. Tomaselli E. Marban J.R. Balser Phenotypic characterization of a novel long-QT syndrome mutation (R1623Q) in the cardiac sodium channel Circulation 97 1998 640-644
26. +-channel exhibiting novel molecular mechanisms of long QT syndrome FEBS Lett 423 1998 5-9
27. B. Campanelli J.M. Chaudron Long term follow up of long QT syndrome treated by overdrive pacing Heart 86 2001 e14-e15
28. R. Chatrath C.J. Porter M.J. Ackerman Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults Mayo Clin Proc 77 2002 226-231
29. J. Kron R.P. Oliver S. Norsted M.J. Silka The automatic implantable cardioverter-defibrillator in young patients J Am Coll Cardiol 16 1990 896-902
30. M.J. Silka J. Kron A. Dunnigan M.D. Dick II Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients Circulation 87 1993 800-807
31. A.M. Thogersen M. Helvind T. Jensen H. Andersen J.R. Jacobsen X. Chen Implantable cardioverter defibrillator in a 4-month-old infant with a vascular heart tumor Pacing Clin Electrophysiol 24 2001 1699-1700
32. H. Watanabe J. Hayashi M. Haga M. Saito H. Suzuki S. Sato Successful implantation of a cardioverter defibrillator in an infant Ann Thorac Surg 72 2001 125-127
33. J.K. Park M.E. Pollock Use of an implantable cardioverter-defibrillator in an eight-month-old infant with ventricular fibrillation arising from a myocardial fibroma Pacing Clin Electrophysiol 22 1999 138-139
34. T. Hoorntje N. Sreeram R. De Vroet Device therapy for malignant neonatal long QT syndrome Int J Cardiol 71 1999 289-290
35. R.E. Tanel J.K. Triedman E.P. Walsh et al. High-rate atrial pacing as an innovative bridging therapy in a neonate with congenital long QT syndrome J Cardiovasc Electrophysiol 8 1997 812-817
36. P.J. Schwartz S.G. Priori M. Cerrone et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome Circulation 109 2004 1826-1833